InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（7 笔）
内部人交易记录
高级管理人员已披露买入
1
已披露卖出
7
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the full record of transactions filed by Dawes Karen A, Director. Officer active across 4 companies, notably Vaccitech plc. Aggregated, 22 disclosures have been published. Split: 1 buy · 7 sells. Total volume traded: €864k. Activity tracked since 4 May 2021. The latest transaction was disclosed on 17 December 2025 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Dawes Karen A
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报22 总计
1,700 股Ordinary SharesSEC:0001104659-26-106323:0
275 股@ US$161.003.3% 占其流量Common StockSEC:0001193125-25-324912:0
973 股0Common StockSEC:0000950170-25-074251:0
2,953 股@ US$67.7113.7% 占其流量Common StockSEC:0000950170-24-073829:0
803 股0Common StockSEC:0000950170-24-062599:0
4,626 股@ US$42.0713.2% 占其流量Common StockSEC:0000950170-24-022581:0
7,392 股@ US$18.129.1% 占其流量Common StockSEC:0000950170-23-045417:0
798 股0Common StockSEC:0000899243-23-013671:0
775 股@ US$227.1713.0% 占其流量Common StockSEC:0000899243-22-030728:0
644 股0Common StockSEC:0000899243-22-020280:0
2,576 股@ US$149.1835.0% 占其流量Common StockSEC:0000899243-22-019772:0
4,783 股@ US$26.1210.5% 占其流量Common StockSEC:0000899243-21-044418:0
64 股@ US$299.021.6% 占其流量Common StockSEC:0000899243-21-043038:0
13 股@ US$290.020.3% 占其流量Common StockSEC:0000899243-21-036134:0
3,459 股@ US$38.7611.0% 占其流量Common StockSEC:0000899243-21-034897:0
924 股@ US$251.1519.3% 占其流量Common StockSEC:0000899243-21-033643:0
2,929 股@ US$41.190.0013% mcap9.1% 占其流量Common StockSEC:0000899243-21-029533:0
288 股@ US$200.014.8% 占其流量Common StockSEC:0000899243-21-029561:0
2,929 股@ US$41.1910.0% 占其流量Common StockSEC:0000899243-21-028505:0
604 股0Common StockSEC:0000899243-21-019705:0
15,000 股@ US$3.223.5% 占其流量Common StockSEC:0000899243-21-019419:0
1,700 股@ US$17.00100.0% 占其流量Ordinary SharesSEC:0001104659-21-062434:0
标准退出：2021年8月2日 (T+90)
22 条申报中的 22 条
About Dawes Karen A
DAWES KAREN A is a Director at Repligen CORP, REPLIGEN CORP and Vaccitech plc. She has 21 filings in total, and across the sampled recent filings the buy and sell amounts are EUR 24053 and EUR 839878, with filings dated from 2021-05-06 to 2025-12-18. The modal transaction nature is Option exercise.
